Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORLAAM Dosing Strategies for Heroin Dependence
NCT00218127Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Nov 2001
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of levacetylmethadol in heroin dependence, sponsored by National Institute on Drug Abuse. Started Nov 2001; status: completed.
02
Drugs
levacetylmethadol
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT00218127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218127.